QAELUM completes € 2 Mio internal investment round to support global growth

Publication date : 31/08/2016

QAELUM N.V., the Belgium-‐‐based international specialist in medical quality monitoring and analysis, announces  it  has  completed  an  internal  capital  round  of  €  2  Mio.  The  capital  is  provided  by QAELUM’s current investors – including Gemma Frisius Fund KU Leuven and business angel Marc Beuls – extended with Dr. Jan Schillebeeckx, the current CMO of the company. The QAELUM team will  use  the  investment  to  further  strengthen  the  management  &  sales  structure  and  expand overseas. QAELUM is a spin-‐‐off of the University Hospitals Leuven. Today, this link is reinforced with Prof. Dr. Frank Rademakers joining QAELUM’s Board of Directors.

Showing confidence in the momentum of QAELUM

QAELUM has grown fast since 2012, when it spun out from the University Hospitals Leuven, Belgium. In  only  four  years,  QAELUM  successively  launched  its  total  quality  monitoring  (TQM)  solutions (tqm|DOSE,  tqm|QBOOK,  tqm|BASELINE,  etc.).  QAELUM’s  integrated  software  suite  monitors, analyses  and  improves  a  range  of  quality  aspects  related  to  patient  radiation  dose.  In  addition,  it guarantees maximum safety of patients and staff in medical imaging departments. Other milestones are the agreements with FUJIFILM and AGFA Healthcare to operate as QAELUM distributors with sales teams promoting and selling tqm|DOSE internationally.

Luc  Vandenbroucke,  Chairman  of  QAELUM  Board  of  Directors:  “Today  QAELUM  announces  a  new milestone with an internal € 2 Mio investment round. I welcome the additional funds as a token of confidence the present shareholders show in the future of QAELUM. These funds will be used mainly to strengthen the management & sales structure and support the geographical expansion.”

Strengthened management team and overseas expansion

The internal investment round primarily includes funds from current shareholders Gemma Frisius Fund KU Leuven, business angel Marc Beuls and the other QAELUM shareholders -‐‐ extended with Dr. Jan Schillebeeckx, CMO of the company since 2013. Dr. Schillebeeckx is a key opinion leader in the field of medical imaging and a European pioneer in PACS and Teleradiology. He is also stakeholder for eHealth at the European Commission. Earlier on he headed the medical imaging department at the Imelda Hospital (Bonheiden, Belgium) for 23 years. 
QAELUM  welcomes  Prof.  Dr.  Frank  Rademakers  as  a  new  member  of  its  Board  of  Directors.  This appointment  illustrates  the  strengthened  collaboration  with  the  University  Hospitals  Leuven,  from which QAELUM originally has spun out from.
CEO  Jurgen  Jacobs:  “I  see  the  internal  investment  round  as  a  confirmation  of  the  exceptional achievements realised by the entire QAELUM team. The investors support our business strategy for the coming years. We will extend our management team and strengthen our sales force. We are going to increase local presence in key EMEA regions and start gaining foothold in hospitals outside Europe and Middle East. In general, we sense a growing awareness of medical radiation and associated risks. Furthermore, medical imaging departments need to adhere to a number of accreditation and auditing obligations.  Our  unique  offering  converts  the  burden  of  lengthy  manual  quality  evaluations  into  a valuable tool for continuous quality improvement. After obtaining CE class IIb classification for the EU market, QAELUM software has now also been approved for use in the US and Canada.”

ABOUT QAELUM N.V.

QAELUM is a high-tech spin-off company of the University Hospitals Leuven. Based on more than 15 years of quality assurance experience in an academic environment as well as in the field, QAELUM is seen  as  the  preferred  partner  when  it  comes  to  medical  imaging  quality  control.  Leading  hospital groups share our vision of a global system for quality assurance, which realises optimal use of radiation and guarantees maximum safety for patients and staff. At the same time, they acquire a more detailed overview of and deeper insights into all quality related aspects.

Passionate about solving real world problems, QAELUM focuses on the development and deployment of highly innovative solutions and services to resolve the daily problems of every medical imaging professional.  Ranging  from  automated  quality  control  in  nationwide  breast  screening  programs  to optimised solutions for local patient dose monitoring, QAELUM has solutions for all these problems regardless of the scale. The combination of advanced software tools and expert knowledge in the field, makes the innovative solutions offering a preferred choice for healthcare professionals.

Contact persons